GGrantIndex
← Search

Program Leaders

$176,122P30FY2012CANIH

Vanderbilt University, Nashville TN

Investigators

Linked publications, trials & patents

Trial NCT07016399Trial NCT06593106Trial NCT05501665Trial NCT05361720Trial NCT04765072Trial NCT02702310Trial NCT02685631Trial NCT02677883Trial NCT02676752Trial NCT02672475Trial NCT02658487Trial NCT02600533Trial NCT02489422Trial NCT02480114Trial NCT02457910Trial NCT02448225Trial NCT02440737Trial NCT02374931Trial NCT02359851Trial NCT02324881Trial NCT02296112Trial NCT02269111Trial NCT02240381Trial NCT02236546Trial NCT02170272Trial NCT02151539Trial NCT02148406Trial NCT01996527Trial NCT01928160Trial NCT01901367Trial NCT01660971Trial NCT01230515Trial NCT01198535Trial NCT01141218Trial NCT01098669Trial NCT01098643Trial NCT01096407Trial NCT01096394Trial NCT01096381Trial NCT01077440Trial NCT01031446Trial NCT01013506Trial NCT01009931Trial NCT01007422Trial NCT00993694Trial NCT00993135Trial NCT00987766Trial NCT00984542Trial NCT00984490Trial NCT00983268Trial NCT00957736Trial NCT00949052Trial NCT00930930Trial NCT00900406Trial NCT00900003Trial NCT00899769Trial NCT00899626Trial NCT00899457Trial NCT00899301Trial NCT00899028Trial NCT00898742Trial NCT00898638Trial NCT00898430Trial NCT00898313Trial NCT00897988Trial NCT00897832Trial NCT00897793Trial NCT00897650Trial NCT00897468Trial NCT00897403Trial NCT00897117Trial NCT00896948Trial NCT00896675Trial NCT00892801Trial NCT00875238Trial NCT00840814Trial NCT00837876Trial NCT00835679Trial NCT00801346Trial NCT00765245Trial NCT00755040Trial NCT00675636Trial NCT00670644Trial NCT00670605Trial NCT00670046Trial NCT00666211Trial NCT00656604Trial NCT00653250Trial NCT00651976Trial NCT00651716Trial NCT00647218Trial NCT00626873Trial NCT00625417Trial NCT00625066Trial NCT00616590Trial NCT00601991Trial NCT00573404Trial NCT00550537Trial NCT00544648Trial NCT00533884

Abstract

Research Proqram Leaders Committee (RPLC) - The RPLC meets on the first Thursday of each month to discuss issues relevant to research opportunities and needs within the VICC. The meeting is co-chaired by the Director and Associate Director for Basic Science Research Programs. Other members include all Research Program Leaders and Co-Leaders, the Deputy Director, the Associate Director of Clinical Science Research Programs, the Associate Director for Prevention, Control and Population-Based Research, the Associate Director for Shared Resources, the Associate Director for CCSG Administration, and the Director Emeritus. This is an important forum in which program leaders exchange information about inter- and intra-programmatic research initiatives and provide updates about ongoing high impact research in each of the programs. Planning for new or modified shared resources, recruitments, inter-programmatic collaborations and other activities to enhance the programs occurs during these meetings. Another important charge of the RPLC is to review new requests for membership in VICC and to make recommendations to the Director. Membership applications are submitted detailing the cancer-related activities of prospective members. The RPLC evaluates the application for compliance with VICC membership criteria, the committee then judges the applicant for suitability for assignment to the appropriate research program and a recommendation is made to the Director, who has ultimate authority in appointing members. The RPLC also conducts an annual review of the VICC membership and assesses cancer-relevant funding and publications, program participation and cancer collaborations for each member. The most recent evaluation occurred in the fall of 2008. The RPLC also plays an important role in review of CCSG Pilot Project applications. The RPLC selects reviewers for the applications and ranks the applications after all reviews have been returned. This ranking process is important as most years only 15-20% of submitted applications can be funded.

View original record on NIH RePORTER →